Showing results (11-20 of 584) with videos related to
Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokersGiannis Mountzios, David Planchard, Benjamin Besse, et al.Plos One|October 11, 2018
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancerAntoine Schernberg, Laura Mezquita, Angela Boros, et al.The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.Targeted Oncology|February 2, 2013
Identification of driver mutations in lung cancer: first step in personalized cancerDavid PlanchardBulletin Du Cancer|June 30, 2015
[Is chemotherapy still a valid option for oncogene-addicted lung cancer? Yes]Benjamin BesseExpert Review of Anticancer Therapy|September 16, 2011
Bevacizumab in non-small-cell lung cancer: a reviewDavid PlanchardCancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.Onkologie|June 19, 2013
Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trialsAntonin Levy, Carlos Gomez-Roca, Christophe Massard, et al.Tumori|May 21, 2016
Crizotinib primary resistance overcome by ceritinib in a patient with ALK-rearranged non-small cell lung cancerFrancesco Facchinetti, Caroline Caramella, Nathalie Auger, et al.British Journal of Cancer|January 4, 2024
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancerLaura Mezquita, Marianne Oulhen, Agathe Aberlenc, et al.Pageof 59